发明名称 Aminothaizoles and their use as adenosine receptor antagonists
摘要 Compounds of formula (I) in free or salt form, where A is a C<SUB>6</SUB>-C<SUB>15 </SUB>monovalent aromatic group. R<SUP>1 </SUP>is hydrogen, phenyl optionally substituted by one or more substituents selected from halogen, cyano, hydroxy, C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl, C<SUB>1</SUB>-C<SUB>8</SUB>-haloalkyl, C<SUB>1</SUB>-C<SUB>8</SUB>-alkoxy, C<SUB>1</SUB>-C<SUB>8</SUB>-alkoxy-C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl or acyloxy, or a 5- or 6-membered monovalent heterocyclic group, R<SUP>2 </SUP>is hydrogen, C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl, acyl or CON(R<SUP>3</SUP>)R<SUP>4</SUP>, provided that R<SUP>2 </SUP>is C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl, acyl or CON(R<SUP>3</SUP>)R<SUP>4 </SUP>when R<SUP>1 </SUP>is hydrogen, R<SUP>3 </SUP>and R<SUP>4 </SUP>are each independently hydrogen, or C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl, together with the nitrogen atom to which they are attached denote a 5- or 6-membered heterocyclic group, and Z<SUP>l</SUP>, Z<SUP>2</SUP>, Z<SUP>3 </SUP>and Z<SUP>4 </SUP>are each independently N or CR<SUP>5</SUP>, at least one of them being CR<SUP>5</SUP>, and R<SUP>5 </SUP>is hydrogen, C<SUB>1</SUB>-C<SUB>8</SUB>-alkyl or C<SUB>1</SUB>-C<SUB>8</SUB>-alkoxy. The compounds are useful as adenosine receptor antagonists, particularly in the treatment of inflammatory or obstrucive airways diseases
申请公布号 US7109202(B2) 申请公布日期 2006.09.19
申请号 US20030432302 申请日期 2003.05.21
申请人 NOVARTIS AG 发明人 PRESS NEIL J;TAYLOR ROGER J
分类号 A61K31/427;C07D417/04;A61K31/4436;A61K31/4439;A61K31/497;A61K45/00;A61P1/04;A61P1/12;A61P1/16;A61P3/10;A61P7/00;A61P7/06;A61P9/10;A61P11/00;A61P11/02;A61P11/06;A61P11/08;A61P13/12;A61P17/00;A61P17/06;A61P17/14;A61P17/16;A61P19/00;A61P21/04;A61P25/28;A61P27/02;A61P27/06;A61P27/14;A61P29/00;A61P35/00;A61P37/02;A61P37/08;A61P43/00;C07D277/42;C07D417/14;C07D521/00 主分类号 A61K31/427
代理机构 代理人
主权项
地址